Global POC Infectious Diseases Market 2015-2019

Global point-of-care infectious disease market forecast

POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. The testing site is usually a patient's bedside, physician's clinic, ICU, operating room, emergency room, or wherever medical care may be necessary. A healthcare professional or a nurse attending the patient will obtain the specimen, perform analysis, and record the result. The main purpose of POC testing is to decrease the time between diagnosis and treatment. This test is either antibody-based or microbial particle-based detection method, which includes ELISA, agglutination, optical immunoassays, or lateral flow immunochromatography. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies. Performing this test for screening infectious diseases extends its applications to the community practice setting. For instance, processing accurate data on the prevalence of influenza in the community could help curtail the inappropriate use of antibacterial agents and improve the allocation of vaccines to areas of highest need. According to the POC infectious diseases industry analysis, Technavio's analysts predict the global POC infectious disease market to grow at a CAGR of 7.50% over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC infectious disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of testing kits and devices used for the major POC infectious diseases in the market. Based on diseases, the market can be divided into 10: flu, tuberculosis, malaria, RSV, adenovirus, infectious mononucleosis, fecal occult blood, HIV, strep. B, others (HCV, HBV, giardia, syphilis, and pneumonia).

Technavio's report, the Global POC Infectious Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global POC infectious disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
• Americas
• APAC
• EMEA
       
Key vendors
• Alere
• Meridian Bioscience
• Orasure Technologies
• Trinity Biotech

Other prominent vendors
• Abbott
• Beckman Coulter/ Danaher
• Becton Dickinson
• Biomerieux
• Bio-Rad
• Cepheid
• Diamedix
• Diasorin
• Eiken Chemical
• Enzo Biochem
• Fujirebio/ Innogenetics
• Grifols/ Novartis Diagnostics
• Humor Diagnostica
• Hologic/ Gen-Probe
• Nanogen/ Elitech
• Ortho-Clinical Diagnostics/ Johnson & Johnson
• Qiagen
• Roche Diagnostics
• SeraCare
• Siemens Healthcare
• Thermo Fisher Scientific

Market driver
• Increase in prevalence of infectious diseases
• For a full, detailed list, view our report

Market challenge
• Lack of awareness about POC devices
• For a full, detailed list, view our report

Market trend
• Shift from physician-centered to patient-centered model
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size, market forecast be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Technavio also provides customized reports based on the specific requirements of our clients.